Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Risperidone
- Therapeutic area
- CNS & mental health
- Drug class
- Antipsychotics
- ATC
- N05AX
- Strength
- 3 mg
- Dosage form
- Tablet
- Pack
- 10's
- Registration no.
- 041575
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-09-23 03:19
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
No change in the official DRAP price is recorded for this pack (10's). Current price PKR 607.08, effective 4 Sep 2025.
Cite this price history
MedInfoBase. Raze 3 mg, 10's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/raze-3-mg-041575-10s-glitz-pharma/ (accessed 24 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 607.08 | 2025-09-04 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 041575Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.
